|
|
|
| Effect of PDCA in prescription audit of pharmacy intravenous admixture services |
| WANG Yan-yan GAO Jie▲ LIU Yan LYU Chang-liang SHAN Ya-nan SUN Le-le |
| Intravenous Drug Dispensation Center, Zibo Central Hospital, Shandong Province, Zibo 255036, China |
|
|
|
|
Abstract Objective To explore the effect of plan-do-check action (PDCA) in prescription auditing of pharmacy intravenous admixture services (PIVAS). Methods Tracked unreasonable medical orders from 2016 to 2019, the PDCA method was used to discover the status of unreasonable medical orders, so as to analyze the reason, formulate corresponding goals and measures and continuous improvement. the reasons were analyzed, corresponding goales and measures were formulated ,then to maked continuous improvement, 2016 was before intervention, 2017 (the first round of intervention), 2018 (the second round of intervention) and 2019 (the third round of intervention) were after the implementation of the intervention. The pre-audit rate of unreasonable medical orders and the proportion of unreasonable medical orders were analyzed before and after intervention. Results After the implementation of three rounds of intervention, the pre-audit rate of unreasonable medical orders in the second and the third rounds of intervention were higher than those before intervention, the differences were statistically significant (P＜0.05). The pre-audit rate of unreasonable medical orders in the third round of intervention was higher than that in the second round, the difference was statistically significant (P＜0.05). There was no significant difference in the pre-audit rate of unreasonable medical orders between the first round of intervention and before intervention (P＞0.05). The proportion of unreasonable medical orders in the third round of intervention was lower than that before intervention, and the difference was statistically significant(P＜0.05). The second round of intervention, some proportion of unreasonable medical orders were compared with those before intervention, the differences were statistically significant (P＜0.05). There was no significant difference in the proportion of unreasonable medical orders between the first round of intervention and before intervention (P＞0.05).Conclusion PDCA circulation management can effectively promote the pre-audit rate of medical orders, reduce the proportion of unreasonable types of medical orders,and then facilitate the clinical rational use of drugs.
|
|
|
|
|
|
| [1] |
国家卫生健康委员会办公厅，国家中医药管理局办公室，中央军委后勤保障部办公厅.关于印发医疗机构处方审核规范的通知（国卫办医发〔2018〕14 号）[S].北京，2018-06-29.
|
| [2] |
张善存，熊飞，宋沛然.PDCA 循环法降低静配中心不合理医嘱漏审的应用研究[J].中国合理用药探索，2019，16（6）：186-189。
|
| [3] |
国家药典委员会.中华人民共和国药典·临床用药须知化学药和生物制品卷[M].2010 版.北京：中国医药科技出版社，2011：872-965.
|
| [4] |
陈新谦，金有豫，汤光.新编药物学[M].17 版.北京：人民卫生出版社，2014：721-773.
|
| [5] |
吴永佩，焦雅辉.临床静脉用药调配与使用指南[M].北京：人民卫生出版社，2010：412-454.
|
| [6] |
张石革，崔嵘，袁英，等.459 种中西药注射剂配伍变化及临床应用检索表[M].北京：北京科学技术出版社，2010.
|
| [7] |
刘华，耿州，王晓兰，等.静脉用药调配中心不合理医嘱的分析和干预[J].中国当代医药，2018，25（3)：94-97.
|
| [8] |
赵森，周爱华，吴林林.我院静脉用药调配中心的不合理医嘱分析[J].中国当代医药，2019，26（7)，177-179.
|
| [9] |
宋晓青，宋岐，张杰，等.品管圈在提高我院PIVAS 排药速度中的应用实践[J].中国药房，2018，29（1）：17-21.
|
| [10] |
曾玉婷，车连容，廖定钦，等.静脉用药调配中心建立责任药师与临床联系制模式研究[J].海峡药学，2019，31（3）：290-292.
|
| [11] |
安卓玲，苏晔，张东肃，等.医院药学教学培训模式的探索实践[J].中国病案，2016，17（7）：93-96.
|
| [12] |
张凌.SBAR 沟通模式在急诊危重病人交接班的应用[J].实用临床护理学电子杂志，2019，4（40）：42-47.
|
| [13] |
郭冬梅.PDCA 循环在降低静脉用药调配中心差错中的应用[J].中国卫生产业，2018，15（20）：82-83.
|
| [14] |
朱江华，李玲，汤卓红，等.PDCA 循环在我院Ⅰ类切口手术抗菌药物预防使用中的应用[J].广东药科大学学报，2019，35（4）：561-564，568.
|
| [15] |
马静，张璐，王牛民，等.责任药师在静脉药物配置中心不合理医嘱干预中的作用[J].中国药房，2015，26（29）：4148-4150.
|
| [16] |
张凤怡，马红，王超璠，等.PDCA 循环管理在外科活血化瘀类中药注射剂临床应用中的成效探讨[J].中国医院用药评价与分析，2020，20（1）：118-121，124.
|
| [17] |
甘丽，何素珍.静脉药物配置中心不合理用药处方回顾性分析[J].临床合理用药，2014，7（3B）：27-28.
|
| [18] |
楚建杰，段佳林，窦芳，等.采用PDCA 循环管理方法规范我院神经外科质子泵抑制剂合理用药的实践[J].中国药房，2019，30（1）：10-14.
|
| [19] |
李超颖.SBAR 沟通模式对产妇满意率的影响研究[J].中国卫生标准管理，2019，10（11）：138-140.
|
| [20] |
周丹丹.门诊药师处方审核情况探讨[J].中国处方药，2019，17（6）：49-50.
|
|
|
|
